The life sciences industry’s real estate demand goes beyond the traditional office or pharma manufacturing site. The processes within the sector call for specialised real estate, e.g. labs with secure water-waste treatment, rapid air circulation and change, or reinforced floors to meet maximum vibration criteria to maintain good manufacturing practices (GMP).
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
